title: The treatment of juvenile myoclonic epilepsy.
abstract: Juvenile myoclonic epilepsy is a common type of epilepsy with onset occurring during adolescence. This review provides a collection of evidence relating to the treatment of this type of epilepsy. Historically, the large majority of patients become seizure-free when treated with valproate. Over recent years, there has been a marked improvement in the pharmacological armamentarium by the physicians. Currently, administration of new antiepileptic drugs, such as levetiracetam, lamotrigine and topiramate, seems to have beneficial effects in the patients with poor response to valproate.
authors.affiliation: University of Chieti, Alberto Verrotti Dept. of Pediatrics, University of Chieti Ospedale Policlinico, Via dei Vestini 5, Italy. averrott@unich.it
authors.forename: Alberto
authors.initials: A
authors.lastname: Verrotti
authors.forename: Rossella
authors.initials: R
authors.lastname: Manco
authors.forename: Giovanna
authors.initials: G
authors.lastname: di Marco
authors.forename: Francesco
authors.initials: F
authors.lastname: Chiarelli
authors.forename: Emilio
authors.initials: E
authors.lastname: Franzoni
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D006801:Humans; D020190:Myoclonic Epilepsy, Juvenile / Q000188:drug therapy*
chemical_list: D000927:Anticonvulsants